SRF
SRF Limited
Diversified chemicals and materials — fluorochemicals, specialty chemicals, packaging films
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
srf.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-19
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
SRF is an Indian manufacturer of chemicals and industrial materials, making refrigerant gases and specialty chemicals, packaging films, technical textiles and coated fabrics.
Company snapshot
1stBy market cap
Ranked among 24 companies in Commodity Chemicals.
Segment mix
Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.
Largest segment: 42.8% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Chemicals Business (CB) | 42.8% | 1,496 Cr | 364 Cr | 11,010 Cr |
| Others | 2.9% | 101 Cr | 16 Cr | 191 Cr |
| Packaging Film Business (PFB) | 39.7% | 1,385 Cr | 90 Cr | 6,635 Cr |
| Technical Textiles Business (TTB) | 14.6% | 510 Cr | 59 Cr | 2,158 Cr |
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,177 Cr | 3,053 Cr | 3,570 Cr | 3,464 Cr | 3,424 Cr | 3,491 Cr | 4,313 Cr | 3,819 Cr | 3,640 Cr | 3,713 Cr | 4,615 Cr | 5,033 Cr |
| Operating expenses (approx.) | 2,551 Cr | 2,487 Cr | 2,874 Cr | 2,861 Cr | 2,886 Cr | 2,872 Cr | 3,356 Cr | 2,989 Cr | 2,866 Cr | 2,933 Cr | 3,589 Cr | 3,797 Cr |
| EBITDA | 626 Cr | 566 Cr | 696 Cr | 603 Cr | 538 Cr | 620 Cr | 957 Cr | 830 Cr | 774 Cr | 780 Cr | 1,026 Cr | 1,237 Cr |
| OPM % | 19.7% | 18.5% | 19.5% | 17.4% | 15.7% | 17.7% | 22.2% | 21.7% | 21.3% | 21.0% | 22.2% | 24.6% |
| Other income | 29 Cr | 19 Cr | 23 Cr | 25 Cr | 33 Cr | 40 Cr | 34 Cr | 29 Cr | 26 Cr | 27 Cr | 25 Cr | 34 Cr |
| Interest | 79 Cr | 67 Cr | 90 Cr | 97 Cr | 94 Cr | 96 Cr | 89 Cr | 80 Cr | 71 Cr | 66 Cr | 62 Cr | 69 Cr |
| Depreciation | 161 Cr | 169 Cr | 186 Cr | 188 Cr | 194 Cr | 194 Cr | 195 Cr | 203 Cr | 212 Cr | 217 Cr | 220 Cr | 223 Cr |
| Profit before tax | 415 Cr | 348 Cr | 443 Cr | 344 Cr | 284 Cr | 369 Cr | 707 Cr | 576 Cr | 517 Cr | 452 Cr | 757 Cr | 979 Cr |
| Tax % | 27.5% | 27.2% | 4.8% | 26.7% | 29.0% | 26.5% | 25.6% | 24.9% | 24.9% | 4.2% | 23.1% | 22.5% |
| Net profit | 301 Cr | 253 Cr | 422 Cr | 252 Cr | 201 Cr | 271 Cr | 526 Cr | 432 Cr | 388 Cr | 433 Cr | 582 Cr | 759 Cr |
| EPS (₹) | ₹10.15 | ₹8.55 | ₹14.24 | ₹8.51 | ₹6.79 | ₹9.15 | ₹17.75 | ₹14.58 | ₹13.10 | ₹14.60 | ₹19.63 | ₹25.60 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,137 Cr | 5,685 Cr | 7,693 Cr | 7,209 Cr | 8,400 Cr | 12,434 Cr | 14,870 Cr | 13,139 Cr | 14,693 Cr | 15,787 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 4,167 Cr | 4,732 Cr | 6,337 Cr | 5,754 Cr | 6,255 Cr | 9,258 Cr | 11,341 Cr | 10,554 Cr | 11,975 Cr | 12,377 Cr | Sign in free for the trailing twelve months |
| EBITDA | 969 Cr | 953 Cr | 1,355 Cr | 1,455 Cr | 2,145 Cr | 3,176 Cr | 3,529 Cr | 2,584 Cr | 2,718 Cr | 3,410 Cr | Sign in free for the trailing twelve months |
| OPM % | 18.9% | 16.8% | 17.6% | 20.2% | 25.5% | 25.5% | 23.7% | 19.7% | 18.5% | 21.6% | Sign in free for the trailing twelve months |
| Other income | 73 Cr | 69 Cr | 40 Cr | 49 Cr | 54 Cr | 43 Cr | 75 Cr | 83 Cr | 133 Cr | 107 Cr | Sign in free for the trailing twelve months |
| Interest | 102 Cr | 124 Cr | 202 Cr | 201 Cr | 134 Cr | 116 Cr | 205 Cr | 302 Cr | 376 Cr | 278 Cr | Sign in free for the trailing twelve months |
| Depreciation | 283 Cr | 316 Cr | 367 Cr | 389 Cr | 453 Cr | 517 Cr | 575 Cr | 673 Cr | 772 Cr | 852 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 657 Cr | 582 Cr | 827 Cr | 1,071 Cr | 1,610 Cr | 2,586 Cr | 2,824 Cr | 1,692 Cr | 1,704 Cr | 2,302 Cr | Sign in free for the trailing twelve months |
| Tax % | 21.6% | 20.6% | 22.4% | 4.8% | 25.6% | 26.9% | 23.4% | 21.1% | 26.6% | 20.3% | Sign in free for the trailing twelve months |
| Net profit | 515 Cr | 462 Cr | 642 Cr | 1,019 Cr | 1,198 Cr | 1,889 Cr | 2,162 Cr | 1,336 Cr | 1,251 Cr | 1,835 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹89.69 | ₹80.41 | ₹111.66 | ₹177.29 | ₹205.54 | ₹63.75 | ₹72.95 | ₹45.06 | ₹42.40 | ₹61.91 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 11.8% | 11.2% | 9.9% | 16.0% | 17.0% | 14.5% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 58 Cr | 58 Cr | 59 Cr | 59 Cr | 60 Cr | 297 Cr | 297 Cr | 297 Cr | 297 Cr | 297 Cr |
| Reserves | 3,124 Cr | 3,506 Cr | 4,071 Cr | 4,875 Cr | 6,796 Cr | 8,268 Cr | 10,030 Cr | 11,182 Cr | 12,329 Cr | 13,745 Cr |
| Borrowings | 1,977 Cr | 2,758 Cr | 3,289 Cr | 3,267 Cr | 2,931 Cr | 3,539 Cr | 4,354 Cr | 4,920 Cr | 4,641 Cr | 5,004 Cr |
| Other liabilities | 1,811 Cr | 2,040 Cr | 2,470 Cr | 2,676 Cr | 3,142 Cr | 3,672 Cr | 4,073 Cr | 4,083 Cr | 4,290 Cr | 5,100 Cr |
| Total liabilities | 6,971 Cr | 8,363 Cr | 9,888 Cr | 10,877 Cr | 12,929 Cr | 15,777 Cr | 18,755 Cr | 20,482 Cr | 21,557 Cr | 24,147 Cr |
| Fixed assets (net) | 4,319 Cr | 5,005 Cr | 5,496 Cr | 6,251 Cr | 7,714 Cr | 8,306 Cr | 9,935 Cr | 13,122 Cr | 13,607 Cr | 13,820 Cr |
| CWIP | 259 Cr | 559 Cr | 754 Cr | 1,393 Cr | 772 Cr | 1,672 Cr | 2,406 Cr | 805 Cr | 811 Cr | 1,889 Cr |
| Investments | 196 Cr | 122 Cr | 101 Cr | 203 Cr | 417 Cr | 321 Cr | 494 Cr | 527 Cr | 827 Cr | 687 Cr |
| Loans & advances | — | — | 11 Cr | 25 Cr | 11 Cr | 9 Cr | 11 Cr | 13 Cr | 17 Cr | 18 Cr |
| Inventories | 838 Cr | 958 Cr | 1,225 Cr | 1,201 Cr | 1,466 Cr | 2,138 Cr | 2,274 Cr | 2,326 Cr | 2,349 Cr | 2,789 Cr |
| Trade receivables | 657 Cr | 681 Cr | 1,029 Cr | 891 Cr | 1,275 Cr | 1,792 Cr | 1,786 Cr | 1,943 Cr | 2,169 Cr | 2,562 Cr |
| Cash & bank | 88 Cr | 87 Cr | 190 Cr | 116 Cr | 138 Cr | 450 Cr | 608 Cr | 399 Cr | 334 Cr | 590 Cr |
| Other assets | 615 Cr | 952 Cr | 1,083 Cr | 796 Cr | 1,137 Cr | 1,088 Cr | 1,241 Cr | 1,346 Cr | 1,442 Cr | 1,791 Cr |
| Total assets | 6,971 Cr | 8,363 Cr | 9,888 Cr | 10,877 Cr | 12,929 Cr | 15,777 Cr | 18,755 Cr | 20,482 Cr | 21,557 Cr | 24,147 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 645 Cr | 700 Cr | 896 Cr | 1,304 Cr | 1,772 Cr | 2,106 Cr | 2,902 Cr | 2,094 Cr | 2,487 Cr | 2,554 Cr |
| Cash from investing | -613 Cr | -1,195 Cr | -1,014 Cr | -1,180 Cr | -1,500 Cr | -1,588 Cr | -2,961 Cr | -2,227 Cr | -1,484 Cr | -1,598 Cr |
| Cash from financing | -284 Cr | 495 Cr | 246 Cr | -199 Cr | -251 Cr | -207 Cr | 220 Cr | -72 Cr | -1,071 Cr | -708 Cr |
| Net cash flow | -252 Cr | -0.62 Cr | 103 Cr | -73 Cr | 22 Cr | 312 Cr | 158 Cr | -209 Cr | -65 Cr | 257 Cr |
| Free cash flow (OCF − Capex) | -29 Cr | -601 Cr | -161 Cr | -85 Cr | 557 Cr | 274 Cr | 36 Cr | -123 Cr | 1,256 Cr | 738 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 14.7% | 11.2% | 13.9% | 15.5% | 17.8% | 22.3% | 20.6% | 12.2% | 12.0% | 13.5% |
| ROE % | 16.2% | 13.0% | 15.5% | 20.7% | 17.5% | 22.1% | 20.9% | 11.6% | 9.9% | 13.1% |
| Debtor days | 47 | 44 | 49 | 45 | 55 | 52 | 44 | 54 | 54 | 59 |
| Inventory days | 128 | 116 | 102 | 119 | 132 | 126 | 116 | 127 | 113 | 129 |
| Days payable | 123 | 126 | 115 | 110 | 143 | 124 | 114 | 120 | 112 | 119 |
| Cash conversion cycle | 51 | 33 | 36 | 54 | 44 | 55 | 46 | 61 | 55 | 68 |
| OCF / EBITDA % | 66.6% | 73.4% | 66.1% | 89.7% | 82.6% | 66.3% | 82.2% | 81.0% | 91.5% | 74.9% |
| OCF / EBITDA % (3 years) | — | — | 68.4% | 77.1% | 80.2% | 76.5% | 76.6% | 76.4% | 84.7% | 81.9% |
| Debt / equity | 0.62 | 0.77 | 0.80 | 0.66 | 0.43 | 0.41 | 0.42 | 0.43 | 0.37 | 0.36 |
| Current ratio | 1.03 | 0.97 | 0.99 | 0.87 | 1.10 | 1.18 | 1.17 | 1.03 | 1.13 | 1.10 |
| Net debt / EBITDA | 1.95 | — | 2.29 | 2.17 | 1.30 | 0.97 | 1.06 | 1.75 | 1.58 | 1.29 |